Metabolic Dysfunction-Associated Steatotic Liver Disease Is Accompanied by Increased Activities of Superoxide Dismutase, Catalase, and Carbonyl Reductase 1 and Levels of miR-200b-3p in Mouse Models

• Egile Nagusiak: Gabriela Svobodová (Egilea), Michaela Šadibolová (Egilea), Eva Velecká (Egilea), Lucia Mráziková (Egilea), Petra Vaculová (Egilea), Petra Matoušková (Egilea), Jaroslav Kuneš (Egilea), Lenka Maletínská (Egilea), Iva Boušová (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Metabolic dysfunction-associated steatotic liver disease (MASLD), one of the leading causes of chronic liver disorders, is characterized by hepatic lipid accumulation. MASLD causes alterations in the antioxidant defense system, lipid, and drug metabolism, resulting in impaired antioxidant status, he...